Departments of1Neurosurgery and.
2Neuroendovascular Program, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; and.
J Neurosurg. 2018 Feb;128(2):567-574. doi: 10.3171/2016.11.JNS161563. Epub 2017 Apr 14.
OBJECTIVE Endovascular thrombectomy in patients with acute ischemic stroke caused by occlusion of the proximal anterior circulation arteries is superior to standard medical therapy. Stentriever thrombectomy with or without aspiration assistance was the predominant technique used in the 5 randomized controlled trials that demonstrated the superiority of endovascular thrombectomy. Other studies have highlighted the efficacy of a direct aspiration first-pass technique (ADAPT). METHODS To compare the angiographic and clinical outcomes of ADAPT versus stentriever thrombectomy in patients with emergent large vessel occlusions (ELVO) of the anterior intracranial circulation, the records of 134 patients who were treated between June 2012 and October 2015 were reviewed. RESULTS Within this cohort, 117 patients were eligible for evaluation. ADAPT was used in 47 patients, 20 (42.5%) of whom required rescue stentriever thrombectomy, and primary stentriever thrombectomy was performed in 70 patients. Patients in the ADAPT group were slightly younger than those in the stentriever group (63.5 vs 69.4 years; p = 0.04); however, there were no differences in the other baseline clinical or radiographic factors. Procedural time (54.0 vs 77.1 minutes; p < 0.01) and time to a Thrombolysis in Cerebral Infarction (TICI) scale score of 2b/3 recanalization (294.3 vs 346.7 minutes; p < 0.01) were significantly lower in patients undergoing ADAPT versus stentriever thrombectomy. The rates of TICI 2b/3 recanalization were similar between the ADAPT and stentriever groups (82.9% vs 71.4%; p = 0.19). There were no differences in the rates of symptomatic intracranial hemorrhage or procedural complications. The rates of good functional outcome (modified Rankin Scale Score 0-2) at 90 days were similar between the ADAPT and stentriever groups (48.9% vs 41.4%; p = 0.45), even when accounting for the subset of patients in the ADAPT group who required rescue stentriever thrombectomy. CONCLUSIONS The present study demonstrates that ADAPT and primary stentriever thrombectomy for acute ischemic stroke due to ELVO are equivalent with respect to the rates of TICI 2b/3 recanalization and 90-day mRS scores. Given the reduced procedural time and time to TICI 2b/3 recanalization with similar functional outcomes, an initial attempt at recanalization with ADAPT may be warranted prior to stentriever thrombectomy.
急性缺血性脑卒中患者的近端前循环动脉闭塞血管内血栓切除术优于标准药物治疗。在证明血管内血栓切除术优越性的 5 项随机对照试验中,支架取栓术联合或不联合抽吸辅助治疗是主要采用的技术。其他研究强调了直接抽吸初次通过技术(ADAPT)的疗效。
为了比较 ADAPT 与支架取栓术治疗急性大血管闭塞(ELVO)患者的血管造影和临床结局,回顾了 2012 年 6 月至 2015 年 10 月期间治疗的 134 名患者的记录。
在此队列中,有 117 名患者符合评估标准。47 名患者采用 ADAPT,其中 20 名(42.5%)需要挽救性支架取栓术,70 名患者采用原发性支架取栓术。ADAPT 组患者的年龄略小于支架取栓组(63.5 岁 vs 69.4 岁;p=0.04);然而,其他基线临床或影像学因素无差异。ADAPT 组的手术时间(54.0 分钟 vs 77.1 分钟;p<0.01)和达到脑梗死溶栓(TICI)分级 2b/3 再通的时间(294.3 分钟 vs 346.7 分钟;p<0.01)显著低于支架取栓术组。ADAPT 组和支架取栓组的 TICI 2b/3 再通率相似(82.9% vs 71.4%;p=0.19)。症状性颅内出血或手术并发症的发生率无差异。90 天时良好的功能结局(改良 Rankin 量表评分 0-2)的发生率在 ADAPT 组和支架取栓组之间相似(48.9% vs 41.4%;p=0.45),即使考虑到 ADAPT 组需要挽救性支架取栓术的患者亚组。
本研究表明,ADAPT 和原发性支架取栓术治疗 ELVO 所致急性缺血性脑卒中在 TICI 2b/3 再通率和 90 天 mRS 评分方面等效。鉴于 ADAPT 治疗的手术时间和 TICI 2b/3 再通时间较短,且功能结局相似,在支架取栓术之前,初次尝试 ADAPT 可能是合理的。